W
WLC

Latest

Longevity Medicine News

Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.

All clinics diagnostics longevity clinics longevity-clinic-comparison regulation best-longevity-clinics evidence-based healthspan industry-news longevity longevity-treatments aging research biohacking clinical-trials clinique-la-prairie longevity-clinics longevity-diagnostics longevity-industry longevity-science NAD-therapy peptide-therapy progevita aging aging-research biomarkers BPC-157 business cleveland-clinic clinic-comparison clinical trials evidence FDA-regulation fountain-life hospital-longevity-programs innovation lanserhof longevity treatments longevity-medicine longevity-medicine-europe NMN NR plasmapheresis preventive-health research sha-wellness-clinic stem cells affordable-longevity-europe aging frailty AI diagnostics AI-drug-discovery allogeneic stem cells Alzheimer-disease AMAALA anti-aging-science anti-aging-treatments ARPA-H Austin-Texas best-longevity-clinics-europe best-longevity-clinics-spain best-longevity-clinics-usa biograph biological age reversal biological-age blood-filtering-therapy buchinger-wilhelmi cellular-senescence centenarians chenot-palace Cleveland Clinic compounding-pharmacies cruise-ship-wellness drug-combo editorial EMA epigenetic-clock epigenetics european-longevity-clinics european-wellness evidence-based-medicine executive health executive-health franchises genomics geroscience Human Longevity human-longevity-inc industry-trends inflammation investment ipamorelin joe-rogan longevity medicine longevity-clinic-europe longevity-clinic-guide longevity-clinics-expansion longevity-expansion longevity-medical-tourism longevity-ranking longevity-testing longevity-tourism luxury-longevity luxury-wellness-europe marketing mayo-clinic media medical tourism men health MSC therapy mTOR inhibitors NAD+ neurodegenerative-disease Niagen oxytocin palazzo-fiuggi peptides performance pharmaceutical-industry prevention privacy programs proteomics protocols rapamycin regenerative regenerative medicine regenerative-medicine regulatory-policy risk Saudi-Arabia senolytics sports medicine startups stem cell therapy TGF-beta therapeutic plasma exchange therapeutic-fasting TPE treatment-comparison treatments United States US-longevity-clinics UT Health San Antonio VO2-max Ways2Well wellness
EMA — CAT Quarterly Highlights (Dec 2025) Peer-reviewed

Advanced Therapies in Europe (ATMPs): What the EMA Is Approving and Why It Matters for Longevity Clinics

The EMA publishes its quarterly ATMP report (Jun–Nov 2025): cell, gene, and tissue therapy. A key regulatory signal for clinics offering stem cells or regenerative therapies.

stem cells regulation EMA
Mount Sinai Health System Peer-reviewed

Mount Sinai Scientists Reverse Aging in Blood Stem Cells — What It Actually Means

A Cell Stem Cell study shows that correcting lysosomal dysfunction in aged mouse blood stem cells restores their regenerative capacity eightfold. Significant, but not a clinic treatment yet.

stem cells aging research